Results 231 to 240 of about 6,087,224 (375)

Nipple Sensation After Superomedial Breast Reduction: A Single Surgeon Study Evaluating Prognostic Factors. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Murray JD   +10 more
europepmc   +1 more source

LOSS OF HETEROZYGOSITY OF THE ESTROGEN-RECEPTOR GENE IN BREAST-CANCER [PDF]

open access: yes, 1995
Barnes, DM   +5 more
core   +1 more source

Meta-analysis of antibiotic prophylaxis in breast reduction surgery

open access: yesPlastic Surgery, 2014
R. Shortt   +3 more
semanticscholar   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang   +16 more
wiley   +1 more source

Predicting Breast Reduction Weight Using the Mass of Breast Ptosis [PDF]

open access: green, 2008
John Murray   +3 more
openalex   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin   +10 more
wiley   +1 more source

Reshaping Our Understanding of Sensation and Pain Following Breast Reduction Surgery. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Remy K   +8 more
europepmc   +1 more source

Effects of breast reduction on pulmonary function.

open access: yesInternational surgery, 2014
Y. Keçeci, Seyhan Dagistan
semanticscholar   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

open access: yesArthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy